PRKCB and neoplasm: This finding therefore provides insight into observations of increased SP1 expression in other tumours such as those of the lung where it contributes to tumour progression, particularly in early stages of the disease44, and where this TF likely also drives the increased levels of PKCβ expression that have been reported in these tumours45, 46.